Compounds > nevadensin
Page last updated: 2024-09-04

nevadensin and 3,7-dimethoxy-5,3',4'-trihydroxyflavone

nevadensin has been researched along with 3,7-dimethoxy-5,3',4'-trihydroxyflavone in 1 studies

Compound Research Comparison

Studies
(nevadensin)		Trials
(nevadensin)		Recent Studies (post-2010)
(nevadensin)		Studies
(3,7-dimethoxy-5,3',4'-trihydroxyflavone)		Trials
(3,7-dimethoxy-5,3',4'-trihydroxyflavone)		Recent Studies (post-2010) (3,7-dimethoxy-5,3',4'-trihydroxyflavone)
400251506

Protein Interaction Comparison

ProteinTaxonomynevadensin (IC50)3,7-dimethoxy-5,3',4'-trihydroxyflavone (IC50)
PlasminogenHomo sapiens (human)1.5
Mitogen-activated protein kinase 10Homo sapiens (human)7.7
Mitogen-activated protein kinase 14Homo sapiens (human)7.7
NADPH oxidase 4Homo sapiens (human)1.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goettert, M; Koch, P; Laufer, S; Merfort, I; Schattel, V1

Other Studies

1 other study(ies) available for nevadensin and 3,7-dimethoxy-5,3',4'-trihydroxyflavone

ArticleYear
Biological evaluation and structural determinants of p38α mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoids.
    Chembiochem : a European journal of chemical biology, 2010, Dec-10, Volume: 11, Issue:18

    Topics: Animals; Flavonoids; Humans; Mitogen-Activated Protein Kinase 10; Mitogen-Activated Protein Kinase 14; Models, Molecular; Protein Kinase Inhibitors; Structure-Activity Relationship

2010